BioMedExperts a Premier Online Scientific Social Network Community

Collexis Holdings, Inc.Dell and Collexis Holdings, Inc., plan to launch today BioMedExperts - an innovative social networking community that will promote collaborative medical research and development. BioMedExperts will allow health care and life sciences professionals to easily connect and collaborate with each other, as well as conduct research by providing 1.4 million biomedical experts with 12 million pre-established network connections from more than 120 countries. The site also provides the ability to analyze all associated professional connections within the network and view scientific publications.

As part of the initiative, Dell will provide computer hardware to power the Collexis-designed BioMedExperts. Dell will also provide marketing support for BioMedExperts, including co-branded marketing efforts and promotions at major life science research conferences.

"Dell believes connecting biomedical scientists through online communities will drive true innovation and progress and is critical to the future of biomedical research. BioMedExperts is a cutting-edge tool that can link researchers from around the globe and enable this new level of collaboration," said James Coffin, Ph.D., vice president and general manager, Dell Health Care and Life Sciences. "The Collexis technology and the BioMedExperts professional community is an example of how technology can connect scientists, enabling them to attack new and more complex cross-disciplinary biological problems. This next-generation professional network platform is a prime example of how Dell works with the world’s most innovative technology companies to drive thought leadership and leading-edge research collaboration."

Bill Kirkland, CEO of Collexis, said, "Collexis is excited about working with an industry leader like Dell, which has an intense focus on success in the life sciences market. We are also delighted to have their support in raising awareness of BioMedExperts among the growing number of biomedical researchers and health care providers who are finding online communities to be a perfect way to share, collaborate and discuss their work and discover new research opportunities. And we see this tool becoming even more valuable to researchers as we add millions of profiles during the next couple of months."

For further information, please visit:
http://www.biomedexperts.com

Related news articles:

About Dell
Dell Inc. (NASDAQ: DELL) listens to customers and delivers innovative technology and services they trust and value. Uniquely enabled by its direct business model, Dell is a leading global systems and services company and No. 34 on the Fortune 500. For more information, visit www.dell.com.

About Collexis Holdings, Inc.
Named a Trend-Setting product of 2007 by KMWorld, Collexis Holdings, Inc., a leading developer of high definition search and knowledge discovery software since 1999, is headquartered in Columbia, South Carolina (USA), with three subsidiaries: Collexis Inc. in Columbia, South Carolina, USA; Collexis, B.V. in Geldermalsen, The Netherlands; and SyynX Solutions GmBH in Cologne, Germany. Collexis proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, websites, e-mails and other digitized content and matches them with a comprehensive list of pre-defined “fingerprinted” concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as “finding needles in many haystacks.” Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis’s current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; University of California, San Francisco; University of South Carolina; Erasmus University Library; Merck & Co.; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Collexis shares of common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, please visit www.collexis.com.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...